EN
HI
Summary
As of 26 Oct, 2026, Orchid Pharma stock price is ₹823.3. During the trading session, the stock has moved between an intraday low of ₹809.05 and an intraday high of ₹880.25. Over the last 52 weeks, Orchid Pharma has traded between ₹480.00 and ₹1143.50.
The stock has recorded a trading volume of 1,70,480 shares,. Its Average Traded Price (ATP) is ₹824.39, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹823.30.
Orchid Pharma has an upper circuit limit of ₹987.95 and a lower circuit limit of ₹658.65. The total value traded stands at ₹14.05 CR, and the delivery percentage for the day is 39.81%.
The stock is currently traded with a market lot size of 1. Orchid Pharma also offers a dividend yield of 0%.
Orchid Pharma Share Price Chart
Orchid Pharma Share Key Metrics
Volume
1.70 L
Market Cap
4930.35 CR
LTQ@LTP
1@823.30
ATP
824.39
Var Margin
22.49 %
Circuit Range
658.65-987.95
Delivery %
39.81 %
Value
14.05 CR
ASM/GSM
No
Market Lot
1
Orchid Pharma Fundamentals
P/E Ratio
570.86
P/B Ratio
3.16
Div. Yield
0
Sector P/E
37.75
Sector P/B
3.16
Sec. Div. Yield
0.54
Orchid Pharma Resistance and Support
Pivot 873.8
Resistance
First Resistance
886.85
Second Resistance
898.15
Third Resistance
911.2
Support
First Support
862.5
Second Support
849.45
Third Support
838.15
Orchid Pharma Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Oct 23 2026 | 879.95 | 823.3 | -5.97% | 880.25 | 809.05 |
| Thu Oct 22 2026 | 877.04 | 875.54 | -1.28% | 885.09 | 860.75 |
| Wed Oct 21 2026 | 885.09 | 886.9 | -0.74% | 911.9 | 872.5 |
Orchid Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-10-20 | Proposal for raising of funds |
| 2026-08-14 | Quarterly Results |
| 2026-05-25 | Audited Results |
| 2026-02-11 | Quarterly Results |
| 2025-11-11 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-26 | Audited Results |
| 2025-02-12 | Quarterly Results |
| 2024-11-11 | Quarterly Results |
| 2024-08-12 | Quarterly Results |
| 2026-08-01 | Allotment of Equity Shares |
Orchid Pharma News
Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Orchid Pharma has signed a licensing and supply agreement with Laboratorio Libra S.A. to introduce Exblifep in nine Latin American markets. The partnership is projected to generate a USD 80 million commercial opportunity over 10 years, with Orchid supplying the finished dosage forms.
Oct 24 2026 17:03:42
Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Raising of Funds
Orchid Pharma's board approved an enabling resolution to raise up to Rs.600 crores. The funds will be raised through equity shares, QIP, preferential issue, or other permissible modes to explore market opportunities.
Oct 20 2026 12:22:45
Read More
Orchid Pharma Management
| Name | Position |
|---|---|
| Ram Gopal Agarwal | Chairman |
| Manish Dhanuka | Managing Director |
Orchid Pharma Similar Stocks
Morepen Laboratories Ltd.
123.54
5.87 (4.99%)
Nephrocare Health Services Ltd.
596.45
-5.95 (0.99%)
Senores Pharmaceuticals Ltd.
1215.30
12.70 (1.06%)
Innova Captab Ltd.
987.30
-9.20 (0.92%)
FDC Ltd.
338.70
-1.75 (0.51%)
Supriya Lifescience Ltd.
818.55
-17.70 (2.12%)
IOL Chemicals And Pharmaceuticals Ltd.
164.14
-7.22 (4.21%)
Artemis Medicare Services Ltd.
284.95
-11.80 (3.98%)
RPG Life Sciences Ltd.
2619.60
-160.60 (5.78%)
Gujarat Themis Biosyn Ltd.
324.00
-29.40 (8.32%)
Orchid Pharma FAQs
The Buying Price of Orchid Pharma share is 823.3 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Orchid Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Orchid Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Orchid Pharma shares is 570.86. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Orchid Pharma shares is 3.16. Useful to assess the stock's value relative to its book value.
To assess Orchid Pharma’s valuation compare Sector P/E, P/B which are 37.75 & 3.16 with sector averages, along with growth rates and financial metrics.
The Market Cap of Orchid Pharma is 4930.35 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Orchid Pharma share price is 1143.50 & 480.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Orchid Pharma belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in ORCHPHARMA
Or Download Choice FinX App
Invest in ORCHPHARMA
